Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1

SIMPLE SUMMARY: Despite the substantial achievements to date, a significant proportion of patients still fail to benefit from immune-checkpoint therapies (ICT). The absence of T cell infiltration and insufficient immune recognition may account for the primary resistance to immune checkpoint therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Changbo, Nagaoka, Koji, Kobayashi, Yukari, Nakagawa, Hidewaki, Kakimi, Kazuhiro, Nakajima, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583214/
https://www.ncbi.nlm.nih.gov/pubmed/34771674
http://dx.doi.org/10.3390/cancers13215508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583214/
https://www.ncbi.nlm.nih.gov/pubmed/34771674
http://dx.doi.org/10.3390/cancers13215508

Ejemplares similares